Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the Swiss market. For this year the analysts expect a dividend of 2,84 CHF per share. The dividend yield is then 3,55 percent. The average dividend yield of the pharmaceutical companies equals a low 1,28 percent.
Tomorrow Novartis will publish her past quarter's results. For this year Novartis 's revenue will be around 48,5 billion CHF. This is according to the average of the analysts' estimates. This is slightly lower than 2016's revenue of 49,44 billion CHF.
The analysts expect for 2017 a net profit of 10,91 billion CHF. The majority of the analysts expects for this year a profit per share of 4,71 CHF. Based on this the price/earnings-ratio is 16,96.
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.